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Abstract
Introduction: Despite significant improvement in the diagnosis and management of this disorder, asthma in the majority of 
Ethiopians remains poorly controlled. Although the prevalence of uncontrolled asthma is a public health problem in Ethiopia, its 
reported prevalence varies from study to study. Hence, this review aims to determine the true prevalence of uncontrolled asthma 
among asthmatic patients in Ethiopia. 
Material and methods: Different database searching engines were used including PubMed, Scopus, Google Scholar, Africa jour-
nal online, World Health Organization (WHO) afro library, and Cochrane review. They were systematically searched for published 
studies on uncontrolled asthma in Ethiopia from 2014 to 2019. Primary search terms were “asthma”, “uncontrolled asthma”, 
“uncontrolled wheezing”, and “Ethiopia”. The Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 
guideline was followed. Publication bias was examined by the funnel plot. The random-effect model was fitted to estimate the 
pooled prevalence of uncontrolled asthma among asthmatic patients. All statistical analysis was done using R version 3.5.3 and 
the RStudio version 1.2.5033 software for Windows. 
Results: The overall pooled prevalence of uncontrolled asthma was found to be 71.67% [95% CI (0.6772; 0.7562)]. 
Potential associated factors were: unscheduled visits, frequency of short-acting beta2-agonist (SABA) use, type of treatment and 
perceived rate of asthma control, low monthly income, age group, presence of comorbidity, moderate persistent asthma, severe 
persistent asthma and use of SABA alone as anti-asthmatic medication, use of biomass fuel for cooking, longer duration of asthma 
(> 30 years), incorrect inhalation technique, and asthma exacerbation in the last 12 months. Self-perceived poor asthma control 
was associated with any activity limitation due to asthma, inconsistent inhaled corticosteroid use, and lack of health education 
on metered-dose inhaler technique [AOR =4.96; 95% CI (1.08–22.89)].
Conclusions: Nearly two-thirds of patients were determined to have uncontrolled asthma. Thus, this evidence suggests that 
attention should be given to asthma patients and health care providers. 
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Introduction 
Approximately 300 million people world-
wide have asthma and recent projections indi-
cate that an additional 100 million people will 
be living with asthma by 2025 [1, 2]. The World 
Health Organization (WHO) reports that there are 
approximately 250,000 asthma deaths per year, 
primarily in low-and middle-income countries 
(LMICs) [3, 4]. As with many other chronic dis-
eases in Ethiopia, rapid urbanization rates have 
been related to a rise in the burden of asthma 
and other allergic diseases [3–6]. The incidence 
of these conditions can, in principle, have the 
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potential to reach higher rates than those seen 
in high-income countries (HICs) due to the pri-
mary effects of parasitic helminthic infections 
on the immune system, as these infections are 
widespread in Ethiopian settings [5]. The Interna-
tional Study of Asthma and Allergy in Childhood 
(ISAAC) stated that the burden of asthma among 
adults in Africa, including Ethiopia, has risen 
and has contributed most to the burden of disease 
through its effects on quality of life [3]. In-patient 
admissions and sales of medications account for 
much of the direct government expenses, while 
the lack of employment due to absenteeism from 
work and decreased education is responsible for 
many of the indirect costs [7, 8].
In Ethiopia, challenges, including those 
resulting from overuse of health facilities, lack 
of qualified personnel and testing equipment, 
and lack of access to and availability of inhaled 
medicines have hampered efforts to improve 
the management of asthma [8, 9]. The lack of 
coordinated health promotion initiatives, such 
as effective control strategies for environmental 
causes, air pollutants, and occupational dust, has 
also led to an increasing burden of disease [10]. 
The WHO has indicated that the rate of regula-
tion of asthma and health responses combatting 
the diease on the continent have been below the 
required requirements and have led to the large 
size of the disease burden [3, 4]. Besides, while 
many African countries have national guidelines 
on the treatment of asthma and other CRDs, these 
guidelines have not been enforced in most rural 
areas [11, 12]. Economic analyses (Placeholder2) 
in many African settings have shown that the 
direct costs of asthma are typically higher than 
indirect costs. Nonetheless, indirect costs reflect 
a relatively higher proportion of overall costs for 
pediatric patients compared to adult patients [8]. 
Moreover, the broader economic strain on individ-
uals, households, employers, and the community, 
owing to the lack of future potential sources of 
livelihood, has also been devastating in many 
resource-poor environments [7]. It is assumed that 
many children with asthma in Africa may fail to 
reach their full potential unless appropriate treat-
ment and control measures are put in place [1]. It 
has been proposed that awareness by health care 
professionals and the public is a critical element 
in reacting to the challenge raised by asthma in 
Africa [3, 13].
By 2015, the urban population of the world 
is projected to rise from 45% to 59%, with more 
than half of this happening in Africa, including 
Ethiopia [8]. The prevalence of asthma and other 
chronic diseases in Africa is also projected to in-
crease due to this increasing population growth, 
impact of subsequent urbanization, and adoption 
of western lifestyles [14]. 
Because of reasons that include these chang-
es, the low output of research, and limited quality 
of health services data on the burden of asthma 
in Africa, it is important to evaluate the available 
data through a systematic review of literature to 
attempt to measure the burden, direct the setting 
of health priorities, and inform the formulation of 
effective health policy responses. Understanding 
the determinants of uncontrolled asthma will also 
help to manage premature death from non-com-
municable diseases (NCD) in general, as well as 
asthma in particular.
This result will also allow the Ministry of 
Health and Clinical Services, facility managers, 
and governmental and non-governmental orga-
nizations to be informed of the determinants of 
uncontrolled asthma and to commit to taking 
action. Besides, this analysis should be used as 
a model for prospective researchers and other 
stakeholders.
Therefore, this study will be trying to assess 
the prevalence and determinants of uncontrolled 
asthma among asthma patients in Ethiopian 
hospitals.
Methods and materials 
Setting
Ethiopia is an east African country and is di-
vided into 9 regions named Tigray, Afar, Amhara, 
Oromia, Somali, Benishangul-Gumuz, Southern 
Nations Nationalities and People Region (SNN-
PR), Gambella, and Harari, as well as two admin-
istrative states (Addis Ababa city administration 
and Dire Dawa city administration).
Search strategy
The search strategy has been applied using 
Online Databases (PubMed/MEDLINE, Google 
Scholar, Web of Science, Cochran Library, Afri-
ca Wide Knowledge, and Africa Index Medicus) 
from 2014 to January 2020. Only articles written 
in English and full-texts published from peer-re-
viewed journals were eligible for inclusion. Pri-
mary search terms were “asthma”, “uncontrolled 
asthma”, and “Ethiopia”. Studies that reported 
associated factors or determinants or predictors 
of uncontrolled asthma only, or did not report the 
magnitude or prevalence of uncontrolled asthma 
were excluded.
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The literature search technique was devel-
oped using the headings of the medical subject 
headings (Mesh), BOOLEAN (AND/OR) operator 
was used.
The last electronic search was run on 30 Jan-
uary 2019. Although no complete study protocol 
was written before starting this review, we devel-
oped and piloted a screening guide to make sure 
that the inclusion criteria were adhered to and 
consistently applied by all review authors. Two re-
viewers (DBT and KGK) independently screened 
the titles, abstracts of all citations retrieved, and 
full-text search results to identify potentially 
eligible studies. The agreement between review 
authors was measured using Cohen’s k statistic. 
Disagreements were resolved by discussion after 
mutual consensus and third-party independent 
review (AH).
Inclusion and exclusion criteria
The following factors were a part of the 
inclusion criteria for our analysis: studies pre-
sented as original articles; studies that assessed 
uncontrolled asthma among patients; studies 
conducted among Ethiopian asthmatic patients 
living in Ethiopia and aged 18 and above; studies 
conducted and published from 2014 to 30 January 
2019; and studies written in English. Studies that 
did not explain the criteria for the level of asthma 
control and studies that didn’t state the number of 
patients with uncontrolled asthma were excluded. 
The types of studies included were all pub-
lished and unpublished observational studies 
(cross-sectional, prospective/retrospective cohort 
studies, or case-control studies). Baseline data 
from randomized controlled trials conducted in 
Ethiopia reporting on the prevalence of uncon-
trolled asthma were also included. Experimental 
studies, letters, reviews, commentaries, editorials, 
case reports, or case series were not included. In 
the case of duplicate reports, the most compre-
hensive and up-to-date version was taken into 
account.
The participants of the study included adult 
populations with known asthma on any form of 
anti-asthmatic medication. Study participants 
should be at least 18 years of age. 
Intervention(s)/exposure(s): On any form of an-
ti-asthmatic medications.
Outcome: Prevalence of uncontrolled asthma 
among people who report taking antihyperten-
sive drugs
Settings: Hospital-based studies.
Publication date: 2014, to January 30, 2019.
Language: No language restriction.
Exclusion criteria
Studies not performed on humans, qual-
itative studies, studies that lack relevant data 
needed to compute the prevalence of uncontrolled 
asthma, studies among children and adolescents 
< 18 years of age, and studies that did not use the 
disease control criteria through the ACQ, C-ACT, 
ACT, or GINA were excluded.
Data extraction and quality assessment
Data extraction used a preconceived and 
standardized data collection form and was per-
formed by two independent authors (DBT and 
KGK). Any discrepancies between these authors 
were reconciled through discussion. Data ex-
tracted comprised information about the year of 
publication, country, objective and design of the 
study, diagnostic criteria of uncontrolled asth-
ma, mean age, sex (male proportion), duration 
of asthma, signs and symptoms, anti-asthmatic 
medications, complications, prevalence and/or 
incidence, and risk factors for uncontrolled 
asthma.
Quality assessment of included studies
The methodological quality of the included 
studies was evaluated using the Newcastle-Ot-
tawa Scale. The Newcastle-Ottawa Scale was 
designed to assess the quality of non-randomized 
studies in meta-analyses. This scale is primarily 
formulated by a star allocation system, assigning 
a maximum of 10 stars for the risk of bias in three 
areas: a selection of study groups (4 or 5 stars), 
comparability of groups (2 stars), and ascer-
tainment of the outcome of interest or exposure 
(3 stars). No validation study provides a cut-off 
score for rating low-quality studies. A priori, 
we arbitrarily established that 0–3, 4–6, and 
7–10 stars would be considered as a high, mod-
erate, and low risk of bias, respectively. 
Data analysis and presentation of results
Data were analyzed using the R software 
V.3.5.3. Data were summarized using ranges, 
means ± SDs, and frequencies (percentages) 
where appropriate. Forest plots were drawn to vi-
sualize the combined prevalence of uncontrolled 
asthma and the extent of statistical heterogeneity 
between studies. Statistical heterogeneity was as-
sessed using the c2 test on Cochrane’s Q statistic 
[20] and quantified by calculating the I2 statistic 
(with values of 25%, 50%, and 75% representative 
of low, medium, and high heterogeneity, respec-
tively) [21]. There was a clinical heterogeneity 
between studies included in this study. The defi-
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nition of uncontrolled asthma was different across 
studies. Consequently, we used a random-effects 
meta-analysis to estimate the overall pooled prev-
alence of uncontrolled asthma. To assess possible 
publication bias, Egger weighted regression meth-
ods were used. A p-value < 0.05 was considered 
indicative of statistically significant publication 
bias. Moreover, other relevant findings were sum-
marized in a narrative format. 
Data management
Based on the inclusion and exclusion criteria, 
a tool has been developed a priori to guide the 
screening and selection process. The tool was 
be piloted and revised before data extraction 
begins. The search results were first be uploaded 
to EndNote software first to remove duplicates.
Selection process
Once data are obtained, two investigators 
will independently screened the titles and ab-
stracts of articles retrieved from the literature 
search against the inclusion criteria. Full texts 
for the eligible titles and/or abstracts including 
those where there is uncertainty were obtained 
for further assessment on whether to include in 
the study or not. Where necessary, authors were 
contacted for additional information to confirm 
the eligibility of studies. Disagreements were 
resolved through discussion and, when needed, 
there was arbitration by a third reviewer. Reasons 
for excluding articles were recorded.
Data collection process
Data were extracted using a standardized 
data extraction form. From the studies included, 
two assessors were independently extracted data 
using the predefined standardized extraction 
form. Disagreements were resolved through dis-
cussion and, when needed, there was arbitration 
by a third reviewer.
Where there is missing information, the cor-
responding author of the study was contacted to 
request the missing information. A maximum of 
three emails will be sent to the corresponding au-
thor to request for additional information before 
excluding the study. For studies appearing in more 
than one published article, we considered the 
one that is most recent, comprehensive, and with 
the largest sample size. For surveys appearing in 
one article with multiple surveys conducted at 
different time points, we shall treat each survey 
as a separate study. For multi-national studies, 
data were separated to show the estimate by 
country level.
Data items
Data on general information, authors, year, 
country, region, type of publication, study char-
acteristics (study design, setting, sample size, 
response rate, mean or median age, or age range), 
data on the diagnosis of asthma, information on 
the use of anti-asthmatic medication/therapy, 
and prevalence estimates of uncontrolled asthma 
among those on treatment were extracted. Where 
anti-asthmatic treatment or prevalence informa-
tion relevant for estimating uncontrolled asthma 
among those on treatment are not available, we 
contacted the corresponding author of the study 
to request the missing information. The preva-
lence of uncontrolled asthma were estimated as 
a percentage of all the participants on treatment 
with an anti-asthmatic.
Outcomes and prioritization
The primary outcome is the prevalence of 
uncontrolled asthma among people who report 
taking anti-asthmatic treatment in Ethiopia.
Risk of bias in individual studies
To assess the risk of bias and quality of stud-
ies included in this review, a tool developed by 
Hoy et al. for prevalence studies was used [15]. 
The tool contains 11 items; items 1–4 assess 
the external validity, 5–10 assess the internal 
validity, and item 11 is a summary of the over-
all risk by the reviewer based on the responses 
of the above 10 items which are scored 1 if yes 
and 0 if no. Studies were classified as having 
either a low (> 8), moderate, or high (≤ 5) risk 
of bias. This exercise was done by two reviewers 
and disagreements were solved by discussion and, 
where necessary, by arbitration involving a third 
reviewer/author.
For each included study, we estimated the 
precision (C) or margin of error considering the 
sample size (SS) and the observed prevalence (p) 
of uncontrolled asthma from the formula:
z2 × p × (1–p)
d2
SS =
where z was the value fixed at 1.96 across 
studies (corresponding to 95% confidence inter-
val). The desirable margin of error is 5% (0.05) 
or lower.
Data synthesis
Crude numerators and denominators from 
the individual studies were used to recalculate the 
study-specific prevalence. Prevalence estimates 
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will be summarized by geographic regions and 
by comorbidities.
A meta-analysis were performed on variables 
that are similar across the included studies. 
Proportions were stabilized using the double arc-
sine transformation, and then, a random-effects 
meta-analysis was performed to determine the 
pooled estimate of the prevalence of uncontrolled 
asthma among patients on anti-asthmatic treat-
ment across studies in Ethiopia.
Heterogeneity was be explored using Co-
chrane’s Q  and quantified by  I2  statistics [16]. 
Subgroup analyses were performed based on the 
following: Regions (Eastern, Western, Central, 
and Southern of Ethopia) to identify the possible 
sources of heterogeneity. The definitions of the 
comorbidities of interest were collected, and 
those with the same definitions were analyzed 
together.
The presence of publication bias was as-
sessed using Egger’s test and funnel plots [17]. 
A p-value of < 0.10 on the Egger’s test was con-
sidered statistically significant for publication 
bias. Inter-rater agreements between the research-
ers involved in study selection and those involved 
in the identification of risk of bias were assessed 
using Cohen’s k coefficient.
Al l  analyses  were  per formed using 
a “metaprop” routine using R version 3.5.3 for 
Windows [18]. Results were reported as pro-




Figure 1 is a flow diagram outlining the pro-
cess of identification and selection of included 
studies. We identified 66 records through a com-
prehensive search among which 35 duplicates 
were identified and removed. Subsequently, we 
screened 26 titles and abstracts and excluded 
18 irrelevant papers. Then, the abstracts of thir-
teen full-text articles were reviewed for eligibility, 
among which eight publications were excluded 
for not reporting the prevalence of uncontrolled 
asthma. At the end of the process, only five 
studies met the inclusion criteria and were thus 
retained for qualitative and quantitative analyses 
(Figure 2).
Prevalence of uncontrolled asthma 
All included studies were observationally 
conducted from 2014 to 2019 in different re-
gions. Five studies were included with a total 
of the sample being 1001. The sample sizes for 
each study were as follows: 243 in Oromia [19], 
197 in Oromia [20], 182 in Addis Ababa [21], 
182 in Addis Ababa [22], 206 in Amhara [23]. 
The prevalence for each study was as follows: 
Jimma University Specialized and Teaching Hos-
pital(JUSH) (71.3%), JUSH (64.4%), Addis Ababa 
(75.8%), Addis Ababa (75.8%), and University of 
Gondar (70%) [19–23]. The overall mean pooled 
prevalence was 71.7% (Figure 2).
Figure 1. Process of the identification and selection of studies for inclusion in the review (PRISMA flow diagram)
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Associated factors of uncontrolled asthma 
The first and second studies were conducted 
in Jimma Specialized Hospital (Southeast Ethi-
opia) from June 1, 2012 to July 31, 2012 and in 
2016, respectively. The third and fourth studies 
were conducted in Addis Ababa (Central Ethi-
opia) in 2017 and 2019, respectively. The fifth 
study was conducted in Gondar (Northwest Ethi-
opia) in 2019 (Table 1). 
Discussion 
The present systematic review with me-
ta-analysis was performed to produce pooled esti-
mates of nationwide results of uncontrolled asth-
ma in Ethiopia among patients with asthma. This 
review emphasizes the burden of uncontrolled 
asthma among patients with asthma in Ethiopia 
for a better understanding of the medical condi-
tion which will help in mitigating the problem of 
uncontrolled asthma throughout the country. In 
addition, this review points out a critical lack of 
a high level of evidence regarding the burden of 
uncontrolled asthma in Ethiopia. Indeed, we have 
recorded only five studies that have assessed the 
prevalence and/or risk factors for uncontrolled 
asthma in Ethiopia. That being said, this review 
highlights the crucial and urgent need to focus 
on the epidemiology of uncontrolled asthma in 
Ethiopia to better understand the condition and 
address specific action plans that will surely 
result in mitigating the morbidity and mortali-
ty due to asthma and its related complications 
throughout the country. 
This meta-analysis showed that the pooled 
estimated of uncontrolled asthma in Ethiopia 
was found to be 71.7% with a 95% CI between 
67.72% and 75.62%. Individually, the prevalence 
of uncontrolled asthma in the studies included 
in our work was varied and ranged from 64.4% 
reported by Fenta et al. [20] to 75.8.2% reported 
by Gebremariam [22]. The reason for these 
variations could be due to the types of diagnotic 
tools and assessment methods.
Our meta-analysis study result was higher 
than the studies conducted in Ethiopia [20, 24], 
Canada [25], Zimbabwe [25], and Morocco [26]. 
This might be due to differences in sample size 
and study design. This study result is lower than 
the studies conducted in Ethiopia [27] and Israel 
[28]. This difference might be due to a difference 
in setting since our hospital is the largest hospital 
in the country and the most complicated patients 
are treated here.
Age, unscheduled visits, frequency of SABA 
use, types of treatment, and perceived rate of asth-
ma control [20]. Low monthly income, presence 
of comorbidities, moderate persistent asthma, 
severe persistent asthma, and use of SABA alone 
as anti-asthmatic medication [21]. Use of bio-
mass fuel for cooking, longer duration of asthma 
(>30 years), incorrect inhalation technique, and 
asthma exacerbation in the last 12 months [22]. 
Self-perceived poor asthma control was associat-
ed with any activity limitation due to asthma and 
inconsistent inhaled corticosteroid use [23]. Lack 
of health education on metered-dose inhaler tech-
nique [AOR = 4.96; 95% CI (1.08–22.89)] [29].
Nonetheless, we conducted this review fol-
lowing the rigor and standards of the industry. 
Besides, and to the best of our knowledge, this 
is the first systematic review and meta-analysis 
drawing a clear picture of the prevalence and 
risk factors for uncontrolled asthma in Ethiopia.
Our findings from the meta-analysis have 
implications in clinical practice because they 
contribute to giving attention to the prevention 
and care of patients with asthma. This pooled 
point of estimates for uncontrolled asthma in 
patients with asthma provides updated evidence 
Figure 2. Forest plot for the pooled prevalence of uncontrolled asthma from 5 observational studies
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to advance prevention strategies, to serve as a key 
indicator of patient safety, to reflect the quality 
of healthcare service, and to further advance 
potential and appropriate treatment strategies 
for uncontrolled asthma in patients with asthma. 
Finding the accurate prevalence of uncontrolled 
asthma will help to improve the use of adher-
ence interventions such as patient education 
and counseling on how to self- monitor, as well 
as lifestyle modification interventions such as 
exercise, weight reduction, and healthy diet. 
Therefore, the asthma treatment strategy should 
keep in mind that in addition to prescribing ap-
propriate anti-asthmatic medications and asthma 
care practice, they need to include resources that 
help patients overcome individual challenges to 
reduce the development of chronic complications 
using self-care practice. The implication of this 
study, particularly the pronounced variation 
between studies (64.4% to 75.8%), reflects that 
patients with asthma require developed standards 
for management and implemented endorsed 
guidelines in clinical practice.
Conclusion 
In this study, the prevalence of uncontrolled 
asthma among asthmatic patients was consid-
erably high. Potential associated factors were: 
unscheduled visits, frequency of SABA use, 
type of treatment and perceived rate of asthma 
control, low monthly income, age, presence 
of comorbidities, moderate persistent asthma, 
severe persistent asthma, use of SABA alone as 
anti-asthmatic medication, use of biomass fuel for 
cooking, longer duration of asthma (>30 years), 
an incorrect inhalation technique, and asthma 
exacerbation in the last 12 months. Self-perceived 
poor asthma control was associated with any 
activity limitation due to asthma, inconsistent 
inhaled corticosteroid use, and lack of education 
on metered-dose inhaler technique. In response 
to this finding, future interventions that target the 
prevalence and resolution of associated factors 
is required.
Strengths and limitations of this study
To the best of our knowledge, this is the first 
and only systematic review and meta-analysis that 
has focused on uncontrolled asthma in Ethiopia.
Strong and reliable methodological and sta-
tistical procedures were used in this review.
Only nine studies were found eligible for 
inclusion in the qualitative and quantitative 
analyses.
The definition of uncontrolled asthma was 
different from one study to another, with a con-
sequential high clinical heterogeneity across 
studies.
Different studies use different variables and 
this results in variation in the significant variables.
Most of the studies did have not separate.
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Figure 3. Funnel plot showing evidence of no publication bias across studies
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